Showing results (101-110 of 143) with videos related to

Sort By:
Pageof 15
Medicine|April 22, 2016
Multiple Serum Cytokine Profiling to Identify Combinational Diagnostic Biomarkers in Attacks of Familial Mediterranean FeverTomohiro Koga, Kiyoshi Migita, Shuntaro Sato, et al.
Internal Medicine (Tokyo, Japan)|November 19, 2019
Drop Head Syndrome as a Rare Complication in Mixed Connective Tissue DiseaseMidori Akagi, Masataka Umeda, Mikiko Hashisako, et al.
Frontiers in Immunology|January 30, 2018
M1 and M2 Monocytes in Rheumatoid Arthritis: A Contribution of Imbalance of M1/M2 Monocytes to OsteoclastogenesisShoichi Fukui, Naoki Iwamoto, Ayuko Takatani, et al.
Internal Medicine (Tokyo, Japan)|March 13, 2018
Rituximab-induced Acute Thrombocytopenia in Granulomatosis with PolyangiitisYushiro Endo, Tomohiro Koga, Midori Ishida, et al.
Arthritis Research & Therapy|December 15, 2016
Fewer subsequent relapses and lower levels of IL-17 in Takayasu arteritis developed after the age of 40 yearsShoichi Fukui, Naoki Iwamoto, Toshimasa Shimizu, et al.
Internal Medicine (Tokyo, Japan)|May 22, 2018
Reversible Cognitive Dysfunction in Elderly-onset Systemic Lupus Erythematosus, Successfully Treated with Aggressive Immunosuppressive TherapyYuya Fujita, Shoichi Fukui, Midori Ishida, et al.
Internal Medicine (Tokyo, Japan)|August 28, 2018
Scleroderma Renal Crisis Complicated with Thrombotic Microangiopathy Triggered by Influenza B Virus InfectionToshimasa Shimizu, Naoki Iwamoto, Momoko Okamoto, et al.
Journal of Bone and Mineral Metabolism|September 7, 2018
Denosumab is effective toward glucocorticoid-induced osteoporosis patients complicated with rheumatic diseases regardless of prior anti-osteoporotic drugsNaoki Iwamoto, Momoko Okamoto, Sosuke Tsuji, et al.
Clinical Immunology (Orlando, Fla.)|October 9, 2018
Podocyte foot process width is a prediction marker for complete renal response at 6 and 12 months after induction therapy in lupus nephritisKunihiro Ichinose, Mineaki Kitamura, Shuntaro Sato, et al.
Plos One|May 5, 2017
Efficacy and safety at 24 weeks of daily clinical use of tofacitinib in patients with rheumatoid arthritisNaoki Iwamoto, Sosuke Tsuji, Ayuko Takatani, et al.
Pageof 15